Endothelium-dependent contractions and endothelial dysfunction in human hypertension

Area of Science:

• Vascular Physiology
• Endothelial Function
• Cardiovascular Disease

Background:

• The endothelium regulates vascular tone and prevents atherosclerosis via substances like nitric oxide (NO).
• Endothelial dysfunction, characterized by reduced NO and increased EDCFs, is linked to atherosclerosis and cardiovascular events.
• Hypertension and aging are associated with impaired endothelial function.

Purpose of the Study:

• To investigate the role of endothelial dysfunction in hypertension.
• To explore the balance between nitric oxide (NO) and endothelium-derived contracting factors (EDCFs) in hypertension.
• To understand the mechanisms transforming the endothelium into a source of vasoconstrictors.

Main Methods:

• Review of evidence on endothelial function in hypertension and aging.
• Analysis of the roles of nitric oxide (NO) and endothelium-derived contracting factors (EDCFs).
• Examination of the effects of cyclooxygenase inhibitors and antioxidants on vasodilation.

Main Results:

• Hypertension is associated with decreased NO bioavailability and increased EDCF production, particularly cyclooxygenase-derived prostanoids and superoxide anions.
• EDCF production, linked to aging, appears to be accelerated in essential hypertension.
• Both indomethacin (a cyclooxygenase inhibitor) and vitamin C (an antioxidant) improved vasodilation in hypertensive patients by restoring NO availability.

Conclusions:

• Hypertension significantly impairs endothelial function, decreasing NO and increasing EDCFs.
• The balance between NO and EDCFs is crucial for maintaining vascular health.
• Further research is needed to elucidate the mechanisms regulating this balance and the transition of the endothelium to a pro-atherosclerotic state.